Methotrexate Therapeutic Cheat Sheet
106261062610626
In this month’s installment of Therapeutic Cheat Sheet, we will review methotrexate and its use in dermatology. Methotrexate has been utilized as therapy for psoriasis and many other dermatologic conditions since its approval by the FDA in 1972.1 While an effective systemic agent for a multitude of dermatologic and non-dermatologic diseases, prescribers should be aware of the side effect profile …
In this month’s installment of Therapeutic Cheat Sheet, we will review methotrexate and its use in dermatology. Methotrexate has been utilized as therapy for psoriasis and many other dermatologic conditions since its approval by the FDA in 1972.1 While an effective systemic agent for a multitude of dermatologic and non-dermatologic diseases, prescribers should be aware of the side effect profile … 
Consumer news articles are revealing patients’ questions about the impact of the deadly pandemic and nationwide protests on their skin, hair, and nail health. How can you prevent breakouts from wearing face masks? Should you avoid oil-based beauty products while protesting? Is ‘COVID toe’ not actually caused by COVID-19?
Be prepared for your patients’ questions about these timely dermat … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients.
Clinicians worldwide are encouraged to report al … 
Psoriasis involves a complex inflammatory cascade mediated by various cytokine effectors. Over the past fifteen years, treatment options have evolved to include biologic medications that provide targeted inhibition of various pathways. IL-23 has emerged as an important inflammatory cytokine in the pathogenesis of psoriasis. We continue our series, Therapeutic Cheat Sheet, with a closer look at IL- … 